It has been reported that CD36 may serve as a biomarker for conjunctival inflammation (Soriano-Romaní et al., 2015) and a critical modulator of proinflammatory and oxidative stress in hypercholesterolemic CKD (Okamura et al., 2009). This evidence concerns the gene CD36 and chronic kidney disease.